Oncology and Hematology

James Armitage, M.D.

Dr. ArmitageProfessor, Internal Medicine
Division of Hematology & Oncology

Academic office:
UNMC Oncology/Hematology Division
987680 Nebraska Medical Center
Omaha, NE 681980-7680

Main practice location:
Peggy D. Cowdery Patient Care Center
Lied Transplant Center
987835 Nebraska Medical Center
Omaha, NE 68198-7835

Ph. 402-559-7290
Fax 402-559-6520

University of Nebraska Medical Center, Omaha, NE, Intern, (1974)
University of Nebraska Medical Center, Omaha, NE, Resident, (1975)
University of Nebraska, Lincoln, NE, B.S., (1969)
University of Nebraska Medical Center, Omaha, NE, M.D., (1973)
University of Iowa Hospitals and Clinics, Iowa City, IA, Fellow, (1977)

Hospital Appointments:
The Nebraska Medical Center
University Hospital

Non-Hodgkin's Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia

Academic Rank: Shapiro Professor of Medicine
Department: Internal Medicine
College: College of Medicine

Membership in Societies:
ASCO; ASH, AFCR, ASCR, ASCR, ASBMT, Royal College of Physicians

Biographical Sketch:
Dr. James O. Armitage graduated from the University of Nebraska Medical Center in 1973 where he completed his internship and residency in internal medicine in 1975. In 1977 he completed a fellowship in hematology-oncology at the University of Iowa Hospitals and Clinics, Iowa City, Iowa. Dr. Armitage was in private practice from 1977-79, and in 1979 he returned to the University of Iowa as an Assistant Professor of Medicine, where he developed and was director of the Bone Marrow Transplantation Program. In 1982 he returned to Nebraska as as Associate Professor of Medicine and was promoted in 1987 to Professor of Medicine. He has served as Vice Chairman of the Department of Medicine (1982-90), Chief of the Division of Oncology/Hematology (1986-89), Chairman of the Department of Internal Medicine (1990-99), Dean, College of Medicine (2000-03), and presently holds the position of the Joe Shapiro Professor of Medicine. He is a member of several professional organizations as well as serving on the editorial boards of several peer-reviewed journals. He serves on several national and international committees and served as President of ASCO (1996-97) and President of ASBMT (2000-01). He has authored or co-authored 440 articles, 95 book chapters, more than 450 abstracts, and is the editor/co-editor of 24 books. He is married to Nancy Armitage and the father of four children and grandfather of three grandchildren.

Select Publications:
Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 45:1551-1557, 2004

Ganti AK, Bierman PJ, Lynch JC, Bociek RG, Vose JM, Armitage JO. Hematopoietic stem cell transplantation in mantle cell lymphoma. Annals of Oncology 16:618-624, 2005

Vose JM, Bierman PJ, Enke C, Hankins J, Bociek G, Lynch JC, Armitage JO. Phase I trial of iodine-131 tositumomab with high dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin’s lymphoma. J Clin Oncol 23:461-467, 2005

Ganti AK, Weisenburger DD, Smith LM, Hans CP, Bociek RG, Bierman PJ, Vose JM, Armitage JO. Patients with Grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy. The Nebraska Lymphoma Study Group Experience. Ann Oncol 17:920-927, 2006

Vose JM, Bierman PJ, Loberiza FR, Bociek RG, Matso D, Armitage JO. Phase I trial of 90Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin’s lymphoma following high-dose chemotherapy and autologous stem cell transplantation. Leukemia & Lymphoma 48:683-690, 2007

Armitage JO. How I treat patients with diffuse large B-cell lymphoma. Blood 110:29-36, 2007

Armitage JO, Vose JM, Weisenburger D. International peripheral t-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124-4130, 2008

Aldoss IT, Weisenburger DD, Fu K, Chan J, Vose JM, Bierman PJ, Bociek RG, Armitage JO. Adult

Burkitt Lymphoma. Oncology (Williston Park) 22:1508-17, 2008

Vose JM, Bierman PJ, Loberiza FR, Lynch JC, Bociek GR, Weisenburger DD, Armitage JO. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. Biol Blood Marrow Transplant 14:36-42, 2008

Abuzetun J, Loberiza F, Vose J, Bierman P, Bociek RG, Enke C, Bast M, Weisenburger D, Armitage J0.
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a
necessary component. British J Haematol 167:531-537, 2009